Researchers investigated the fate of A+ cells during pair-feeding by lineage-tracing, somatically ablated ALDH1A3 in diabetic β-cells, and used a novel selective ALDH1A3 inhibitor to treat diabetes.
[Nature Communications]
Home Newsletters Immune Regulation News Genetic and Pharmacologic Inhibition of ALDH1A3 as a Treatment of β-Cell Failure
